Latest News & Features

Reset all filters
Article Type
Channels & Sectors
Geography
Company

Refine Search
Biotechnology
The patenting of personalised healthcare inventions has proved problematic in a 
number of jurisdictions, but various aspects of these inventions are patentable in Europe, as Laurence Gainey of HGF explains.   12 October 2018
Americas
Biologics patent owners should consider the US International Trade Commission as a supplement (or alternative) to district court litigation, say Filko Prugo, Charlotte Jacobsen, Matt Rizzolo and Henry Huang of Ropes & Gray.   10 October 2018
Americas
A proposed amendment in Mexican law needs to be implemented urgently in order to adapt legislation to include provisions in accordance with the UPOV Convention, as Luz Flores of Uhthoff, Gómez Vega & Uhthoff reports.   10 October 2018
Americas
A former Johnson & Johnson IP counsel and a retired judge are among the speakers at Life Sciences IP Due Diligence, on November 29 and 30 in Boston, as LSIPR finds out.   10 October 2018
Biotechnology
Depending on the facts and the content of the applications, an Arrow-type declaration could be made on grounds of insufficiency against divisional applications, say David Holt and Tony Proctor of Potter Clarkson.   8 October 2018
Americas
Patenting antibodies across different jurisdictions can be a difficult task, as Kathy Coulter, senior IP counsel at Bristol-Myers Squibb, tells LSIPR.   4 October 2018
Americas
Costa Rica has released new rules for the clinical investigation of adult stem cells, as María del Pilar López and Esteban Monge of Zürcher Lawyers report.   4 October 2018
Asia
A recent case in India reveals the various ways in which pharmaceutical patents can be challenged, as Neeti Wilson, Arpita Kulshreshtha and Gitika Suri of Anand and Anand report.   2 October 2018
Europe
BIO-Europe heads to Scandinavia for the first time, as Copenhagen plays host in November. LSIPR finds out more.   2 October 2018
article
The issue of inefficiencies in the life sciences IP market is a hot topic to be discussed at the Life Science IP Forum in London in November, as LSIPR finds out.   1 October 2018